Twitter | Search | |
This is the legacy version of twitter.com. We will be shutting it down on 15 December 2020. Please switch to a supported browser or device. You can see a list of supported browsers in our Help Center.
Clinical Cancer Research
Follow Clinical Cancer Research for innovative clinical trials and precision medicine. Published by .
1,836
Tweets
205
Following
2,022
Followers
Tweets
Clinical Cancer Research 1h
Phase 3 Study: PAM50MET prognostic model for HR+, HER2- MBC.
Reply Retweet Like
Clinical Cancer Research 19h
Phase 1b Study: The PLK1 inhibitor onvansertib in combinations for R/R AML.
Reply Retweet Like
Clinical Cancer Research retweeted
Cancer Research Dec 2
Read the recently published abstracts from the virtual Special Conference on Epigenetics and Metabolism:
Reply Retweet Like
Clinical Cancer Research 22h
Phase 1 Study: Concurrent crizotinib and enzalutamide in CRPC.
Reply Retweet Like
Clinical Cancer Research Dec 3
Phase 1 Study: Pexidartinib in refractory pediatric tumors.
Reply Retweet Like
Clinical Cancer Research Dec 2
DNA methylation profiling of premalignant lesions as a path to ovarian cancer early detection.
Reply Retweet Like
Clinical Cancer Research Dec 2
Interleukin-12 message in a bottle:
Reply Retweet Like
Clinical Cancer Research retweeted
AACR Dec 1
Deadline: Dec 21. Submit an abstract for the AACR virtual meeting on and Cancer, Feb 3-5, 2021, organized by program committee chair .
Reply Retweet Like
Clinical Cancer Research Dec 2
Next-generation sequencing of cerebrospinal fluid: How can a liquid be like a solid?
Reply Retweet Like
Clinical Cancer Research retweeted
Dana-Farber Hale Pancreatic Cancer Center Dec 1
Published in , Sara Väyrynen and colleagues in the Wolpin-Nowak Lab used multiplex IF and machine learning to characterize myeloid cell populations in and found that both composition 🧩 and spatial configuration 🧭 are prognostic.
Reply Retweet Like
Clinical Cancer Research Dec 1
by Li et al demonstrates that GC027, an “off-the-shelf” allogeneic CAR-T product targeting T cell antigen CD7 has a potential to be a promising new approach for treating patients with T-cell acute .
Reply Retweet Like
Clinical Cancer Research retweeted
Cancer Research Dec 1
Watch the recording of the recent Journals Webinar – Code Ocean: A Tool to Support the Delivery of Reproducible Analysis with .
Reply Retweet Like
Clinical Cancer Research retweeted
FDA Oncology Dec 1
In the 1st year of , collaborating regulatory agencies approved 38 oncology marketing applications. Read more about this project . via
Reply Retweet Like
Clinical Cancer Research retweeted
Lewis Lab MSKCC Dec 1
It's out in CCR Dec 1st! Led by the amazing who is off to WUSTL soon for her tenure track professorship. "Acute Statin Treatment Improves Antibody Accumulation in EGFR- and PSMA-Expressing Tumors
Reply Retweet Like
Clinical Cancer Research retweeted
Humphrey Lab Nov 30
How do we reliably translate robust pre-clinical findings into the clinic? Here we consider the challenges of combining chemo- and radiotherapy with cell cycle checkpoint kinase inhibitors, with the aim of improving success in clinical trials.
Reply Retweet Like
Clinical Cancer Research retweeted
AACR Dec 1
Funding opportunities are available for projects conducted by holding a doctoral degree. For a full listing of available opportunities and eligibility details, please visit our website:
Reply Retweet Like
Clinical Cancer Research retweeted
AACR Nov 30
This month’s Editors’ Picks include a comparison of persistent opioid use following major surgery among patients with and without cancer, results from two clinical trials, and the preclinical development of an antibody-drug conjugate. :
Reply Retweet Like
Clinical Cancer Research retweeted
Toni Choueiri, MD Nov 30
1/ Just published in : Expression of T-cell Exhaustion Molecules and hERVs as Predictive Biomarkers for response to Nivolumab in Metastatic ccRCC
Reply Retweet Like
Clinical Cancer Research Dec 1
The December 1 issue is online!
Reply Retweet Like
Clinical Cancer Research Nov 30
PD-L1 inhibitor LY3300054 proves to be safe and shows durable in advanced in combination with , and in this phase Ia/Ib trial.
Reply Retweet Like